VORXAR 4MG

About

Voriconazole is a potent, broad-spectrum triazole antifungal agent indicated for the treatment of severe and life-threatening invasive fungal infections. Its mechanism of action involves the inhibition of fungal cytochrome P450-dependent 14-alpha-demethylase, a crucial enzyme in the biosynthesis of ergosterol, a vital component of the fungal cell membrane. By disrupting ergosterol synthesis, voriconazole impairs the structural integrity and function of the fungal cell membrane, leading to fungistatic or fungicidal effects depending on the fungal species and concentration. It demonstrates excellent activity against a wide array of pathogenic fungi, including various Candida species (even those resistant to fluconazole), Aspergillus species, and emerging molds like Scedosporium and Fusarium. Voriconazole exhibits complex, non-linear pharmacokinetics, necessitating careful dose titration and therapeutic drug monitoring due to significant inter-patient variability and potential drug interactions.

Uses

• Invasive aspergillosis
• Esophageal candidiasis
• Serious Candida infections (including C. krusei)
• Scedosporiosis and fusariosis

Directions For Use

Take at least one hour before or one hour after a meal. Follow the exact dosing schedule provided by your doctor.

Benefits

• Broad-spectrum antifungal activity
• Effective against resistant fungal strains
• Available in oral and intravenous forms
• Penetrates into the central nervous system
• Can be life-saving for severe infections
• Improved survival rates in certain invasive fungal infections

Side Effects

• Visual disturbances (blurred vision, altered color perception)
• Fever
• Nausea
• Vomiting
• Diarrhea
• Headache
• Rash
• Liver enzyme elevation
• Photosensitivity
• Hallucinations
• Peripheral edema
• Renal dysfunction

Safety Measures

• Alcohol - Avoid alcohol as it can increase the risk of liver toxicity and may interact with voriconazole's metabolism.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm. Effective contraception must be used during treatment.
• Breastfeeding - Not recommended during breastfeeding due to potential for serious adverse effects in the infant.
• Liver - Use with caution and monitor liver function closely. Dosage adjustment is required in patients with mild to moderate hepatic impairment. Contraindicated in severe hepatic impairment.
• Kidney - Oral voriconazole does not require dosage adjustment for renal impairment. However, the intravenous formulation contains cyclodextrin, which can accumulate in renal dysfunction, so oral is preferred.
• Lung - No specific contraindications related to lung conditions, but careful monitoring is needed in patients with underlying respiratory issues if they develop drug-related lung toxicity.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.